speb/financial-data huggingface dataset:
Stock screener scorecard for ASIANENE.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.462170569188734 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 7.941655606851233%
Earnings yield: 0.028144844317990293%
Return on net tangible assets: 6.612294425805768%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.352868357274339%
Revenue growth: 36.66616279172%
Rule of 40 score: 36.66616279172
Market cap: 17283952640 (Large Cap ($10B-$200B))
Debt to equity: 0.32049999999999995
Operating income: 4516437.049597287
Net income: 3460353.9635438747
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ASIANENE.NS (annual, report date 2026-03-31)
Altman Z-score: 4.076930843392528 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 14.254285189313851%
Earnings yield: 0.050516498999449544%
Return on net tangible assets: 2.0373794642793865%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.197485223817946%
Free cash flow margin: -2.130162853684513%
Revenue growth: 54.203893897855984%
Rule of 40 score: 52.073731044171474
Market cap: 17283952640 (Large Cap ($10B-$200B))
Debt to equity: 0.32049999999999995
Free cash flow (dilution adjusted): -1785777.8719796524
Operating income: 8106443.408223824
Net income: 5493715.557439593
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AVEX (quarterly, report date 2026-03-31)
Altman Z-score: 1.9961310467583657 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 15.21132980389539%
Earnings yield: 2.724379141372666%
Return on net tangible assets: -28.204320077441718%
Capitalized R&D asset: 9695300
ROCI (R&D adjusted): 4.696972847858481%
Rosenberg metric: 5.630347734457324
Free cash flow margin: -5.371654829643782%
Revenue growth: 306.8740846445604%
Rule of 40 score: 301.50242981491664
Market cap: 806961024 (Small Cap ($300M-$2B))
Debt to equity: 0.7776000000000001
Free cash flow (dilution adjusted): -11640000
Operating income: 29623000
Net income: 20998000
Long score: 3 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for EROK (quarterly, report date 2026-03-31)
Altman Z-score: 0.8552369887458976 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 9.386634116570033%
Earnings yield: 0.7366786655559328%
Return on net tangible assets: -2.5884558582937593%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.342744423034448%
Free cash flow margin: -14.09177654406662%
Revenue growth: 226.20260328239956%
Rule of 40 score: 212.11082673833295
Market cap: 541693504 (Small Cap ($300M-$2B))
Debt to equity: -7.757717980809345
Free cash flow (dilution adjusted): -3249000
Operating income: 6152000
Net income: 3363000
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 3200.HK (quarterly, report date 2025-12-31)
Altman Z-score: 7.798741243550328 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 8.486922329899555%
Earnings yield: 0.12372197388959441%
Return on net tangible assets: 5.014587630976462%
Capitalized R&D asset: 33409585.913885236
ROCI (R&D adjusted): 7.7682733863635%
Free cash flow margin: 44.10773900041483%
Rule of 40 score: 44.10773900041483
Market cap: 52323827712 (Large Cap ($10B-$200B))
Debt to equity: 0.0436
Free cash flow (dilution adjusted): 117838126.18428572
Operating income: 57650922.24857143
Net income: 47508730.23857143
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3200.HK (annual, report date 2025-12-31)
Altman Z-score: 8.374642753365787 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 22.57337125153199%
Earnings yield: 0.3290735958243671%
Return on net tangible assets: 13.18358741562475%
Capitalized R&D asset: 98836783.50547595
ROCI (R&D adjusted): 17.546494759962744%
Rosenberg metric: 4.401954958902191
Free cash flow margin: 0.4030351336243052%
Revenue growth: 80.08323114738181%
Rule of 40 score: 80.48626628100611
Market cap: 52323827712 (Large Cap ($10B-$200B))
Debt to equity: 0.0436
Free cash flow (dilution adjusted): 3323851.18
Operating income: 153338939.6442857
Net income: 117752559.82000001
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for EMPG (annual, report date 2024-12-31)
Altman Z-score: 127.90905888846055 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 39.58522056751449%
Earnings yield: 0.9007543378663659%
Return on net tangible assets: 68.90570467336737%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 39.5852205675145%
Free cash flow margin: -0.3002918683806337%
Revenue growth: 53.35543922879733%
Rule of 40 score: 53.0551473604167
Market cap: 143046400 (Micro Cap ($50M-$300M))
Debt to equity: 0.9992
Free cash flow (dilution adjusted): -3692.825112107623
Operating income: 246612.10762331838
Net income: 168466.3677130045
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for 1609.HK (quarterly, report date 2025-12-31)
Altman Z-score: 31.516756988459832 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 8.484930014846318%
Earnings yield: 0.12034223617094172%
Return on net tangible assets: 7.313670159981374%
Capitalized R&D asset: 2592700.978473581
ROCI (R&D adjusted): 9.040174001332481%
Free cash flow margin: 50.58210050600641%
Rule of 40 score: 50.58210050600641
Market cap: 7681871872 (Mid Cap ($2B-$10B))
Debt to equity: 0.0321
Free cash flow (dilution adjusted): 9353714.285714285
Operating income: 7478714.285714285
Net income: 6728285.714285715
Long score: 6 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for 1609.HK (annual, report date 2025-12-31)
Altman Z-score: 32.35445351539873 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 26.498246319215284%
Earnings yield: 0.3758261071197004%
Return on net tangible assets: 19.414562944885766%
Capitalized R&D asset: 11830748.533115344
ROCI (R&D adjusted): 23.986075675803235%
Rosenberg metric: 2.250133070515868
Free cash flow margin: 30.210725733766026%
Revenue growth: 28.397236829061328%
Rule of 40 score: 58.60796256282735
Market cap: 7681871872 (Mid Cap ($2B-$10B))
Debt to equity: 0.0321
Free cash flow (dilution adjusted): 17382000
Operating income: 23355857.14285714
Net income: 19567142.85714286
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BBOX.NS (quarterly, report date 2026-03-31)
Altman Z-score: 3.65980224389264 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.725986985739693%
Earnings yield: 0.009276397113684423%
Return on net tangible assets: 11.75242283173449%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.002574359380571%
Revenue growth: -3.0666330073113945%
Rule of 40 score: -3.0666330073113945
Market cap: 138252091392 (Large Cap ($10B-$200B))
Debt to equity: 0.8959
Operating income: 13385968.630775753
Net income: 6863077.575243748
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BBOX.NS (annual, report date 2026-03-31)
Altman Z-score: 4.979722359410724 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 23.450163477001393%
Earnings yield: 0.03234217212354007%
Return on net tangible assets: 32.14720007861152%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 17.44148283100321%
Free cash flow margin: 0.1858633153270008%
Revenue growth: -3.954723007574698%
Rule of 40 score: -3.7688596922476973
Market cap: 138252091392 (Large Cap ($10B-$200B))
Debt to equity: 0.8959
Free cash flow (dilution adjusted): 1245231.030097499
Operating income: 46670199.236964814
Net income: 23052140.737600677
Long score: 11 | Short score: 2
Recommendation: Long
Stock screener scorecard for BAYN.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.5962595092061069 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 24.217462932454698%
Earnings yield: 5.226123978965944%
Return on net tangible assets: -18.918378567501374%
Capitalized R&D asset: 3320081541.58215
ROCI (R&D adjusted): 4.50233094989403%
Rosenberg metric: 0.745989282938602
Free cash flow margin: -16.449086161879897%
Revenue growth: 14.502877080431626%
Rule of 40 score: -1.9462090814482718
Market cap: 45250453504 (Large Cap ($10B-$200B))
Debt to equity: 1.3427
Free cash flow (dilution adjusted): -2534482758.62069
Operating income: 4055172413.7931037
Net income: 3180459770.1149426
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ANDHRSUGAR.NS (annual, report date 2026-03-31)
Altman Z-score: 3.491568579927531 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 7.163624512314107%
Earnings yield: 0.15817685782442836%
Return on net tangible assets: 7.038727811592825%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.349153981112189%
Free cash flow margin: 9.04238104149783%
Revenue growth: 10.685110995627404%
Rule of 40 score: 19.727492037125234
Market cap: 11700770816 (Large Cap ($10B-$200B))
Debt to equity: 0.0003
Free cash flow (dilution adjusted): 23631284.44256041
Operating income: 13256655.362441713
Net income: 9233573.548113607
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for ANDHRSUGAR.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.499969976248466 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 1.4829224679719502%
Earnings yield: 0.03274376204082716%
Return on net tangible assets: 1.6487279480392767%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.3143211338087486%
Revenue growth: -3.949576183773783%
Rule of 40 score: -3.949576183773783
Market cap: 11700770816 (Large Cap ($10B-$200B))
Debt to equity: 0.0003
Operating income: 2744224.2475625267
Net income: 627490.462060195
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 7688.HK (annual, report date 2025-12-31)
Altman Z-score: 4.162181339564094 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 14.3265221878225%
Earnings yield: 0.10537415215081541%
Return on net tangible assets: -1.940468627377703%
Capitalized R&D asset: 27786769.970356792
ROCI (R&D adjusted): 9.21255597788617%
Rosenberg metric: 0.15094417077175692
Free cash flow margin: -3.8511846471665008%
Revenue growth: 13.39322399037651%
Rule of 40 score: 9.54203934321001
Market cap: 5590544384 (Mid Cap ($2B-$10B))
Debt to equity: 1.9343000000000001
Free cash flow (dilution adjusted): -3179857.1428571427
Operating income: 4958000
Net income: 510428.5714285714
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BAJAJHIND.NS (annual, report date 2026-03-31)
Altman Z-score: 0.42520345830090556 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.328882402260659%
Earnings yield: 0.024868786337342953%
Return on net tangible assets: 5.969600906934268%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.8257441111601775%
Free cash flow margin: 2.1056838431021716%
Revenue growth: -11.265269445367968%
Rule of 40 score: -9.159585602265796
Market cap: 40766124032 (Large Cap ($10B-$200B))
Debt to equity: 0.93
Free cash flow (dilution adjusted): 12172530.733361594
Operating income: 15905044.510385757
Net income: 13419881.305637982
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BAJAJHIND.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.19969602285897028 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 7.095834017238856%
Earnings yield: 0.05301021746521445%
Return on net tangible assets: 11.655784855037474%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.891749724155466%
Revenue growth: 15.002326561587193%
Rule of 40 score: 15.002326561587193
Market cap: 40766124032 (Large Cap ($10B-$200B))
Debt to equity: 0.93
Operating income: 33903136.922424756
Net income: 41407376.00678253
Long score: 2 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BAJAJHCARE.NS (annual, report date 2026-03-31)
Altman Z-score: 2.8582238688855104 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 13.75644476727625%
Earnings yield: 0.0630211711419874%
Return on net tangible assets: 0.5374792888619876%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.080218060625512%
Free cash flow margin: 2.2452528626188446%
Revenue growth: 2.085281786584716%
Rule of 40 score: 4.33053464920356
Market cap: 9896821760 (Mid Cap ($2B-$10B))
Debt to equity: 0.4673
Free cash flow (dilution adjusted): 1453921.1530309455
Operating income: 8188787.621873675
Net income: 1670845.6973293768
Long score: 8 | Short score: 3
Recommendation: Long
Stock screener scorecard for BANSALWIRE.NS (annual, report date 2026-03-31)
Altman Z-score: 4.921526388068913 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 15.705539526939564%
Earnings yield: 0.04780117639559241%
Return on net tangible assets: -0.8502056836491116%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.54472250148096%
Free cash flow margin: 2.4172156933072997%
Revenue growth: 7.521603555832888%
Rule of 40 score: 9.938819249140188
Market cap: 48281853952 (Large Cap ($10B-$200B))
Debt to equity: 0.38770000000000004
Free cash flow (dilution adjusted): 10656104.281475201
Operating income: 26808287.40991946
Net income: 17056167.867740568
Long score: 9 | Short score: 2
Recommendation: Long
Stock screener scorecard for BCG.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.8309673799385677 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.079530118960279%
Earnings yield: 0.7459543093154386%
Return on net tangible assets: 3.190362526730919%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.204316967223069%
Revenue growth: -31.94386140673831%
Rule of 40 score: -31.94386140673831
Market cap: 18974105600 (Large Cap ($10B-$200B))
Debt to equity: 0
Operating income: 35950233.14963968
Net income: 22025360.32217041
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for BCG.NS (annual, report date 2026-03-31)
Altman Z-score: 2.5764629507553556 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 17.22314286448901%
Earnings yield: 3.1493032935360263%
Return on net tangible assets: 10.908251126308825%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 13.52812880412182%
Free cash flow margin: -6.833854056426546%
Revenue growth: 22.029922926111986%
Rule of 40 score: 15.19606886968544
Market cap: 18974105600 (Large Cap ($10B-$200B))
Debt to equity: 0
Free cash flow (dilution adjusted): -50175222.55192878
Operating income: 151776303.51844
Net income: 101984590.92835948
Long score: 5 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for ASTRAMICRO.NS (annual, report date 2026-03-31)
Altman Z-score: 17.072623093602843 (Safe Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 21.129714718645218%
Earnings yield: 0.017812209062423975%
Return on net tangible assets: 12.13962009670474%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.733710270585252%
Free cash flow margin: 26.151529203262193%
Revenue growth: 0.27904182974610997%
Rule of 40 score: 26.430571033008302
Market cap: 172173279232 (Large Cap ($10B-$200B))
Debt to equity: 0.2188
Free cash flow (dilution adjusted): 32226621.449766852
Operating income: 30735523.526918184
Net income: 20450487.494701143
Long score: 13 | Short score: 0
Recommendation: Long
Stock screener scorecard for ASTRAMICRO.NS (quarterly, report date 2026-03-31)
Altman Z-score: 16.499991447037868 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 10.889918796932445%
Earnings yield: 0.009180129162492468%
Return on net tangible assets: 9.08857978523218%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.170440314522331%
Revenue growth: 78.48306863470721%
Rule of 40 score: 78.48306863470721
Market cap: 172173279232 (Large Cap ($10B-$200B))
Debt to equity: 0.2188
Operating income: 15840599.830436626
Net income: 11231252.649427723
Long score: 7 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for SEM (quarterly, report date 2026-03-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 4.511770403890048%
Earnings yield: 1.9638975584981726%
Return on net tangible assets: -5.8922027306647164%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.9405258730867923%
Free cash flow margin: -1.8062914885654067%
Revenue growth: 1.7787050866583516%
Rule of 40 score: -0.02758640190705508
Market cap:  (Unknown)
Debt to equity: 1.420147098138077
Free cash flow (dilution adjusted): -25676000
Operating income: 98418000
Net income: 63775000
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for INIO (quarterly, report date 2026-03-31)
Altman Z-score: 2.3484776216381618 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 5.342477351621371%
Earnings yield: 0.33234541528889233%
Capitalized R&D asset: 47273825.58720639
ROCI (R&D adjusted): 2.073003582847806%
Rosenberg metric: 2.996724435709608
Free cash flow margin: 20.5504038288962%
Revenue growth: 43.12252780492347%
Rule of 40 score: 63.67293163381967
Market cap: 19710001152 (Large Cap ($10B-$200B))
Debt to equity: 12.458499999999999
Free cash flow (dilution adjusted): 157931034.4827586
Operating income: 72528735.63218391
Net income: -8275862.068965517
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for 6656.HK (annual, report date 2025-12-31)
Altman Z-score: 11.8045620348432 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 109.13290870658186%
Earnings yield: 4.588709810713983%
Return on net tangible assets: 69.20783865014585%
Capitalized R&D asset: 105255317.23104364
ROCI (R&D adjusted): 73.09124740835439%
Rosenberg metric: 14.53789300586052
Free cash flow margin: -9.572055456400703%
Revenue growth: 605.8189214454263%
Rule of 40 score: 596.2468659890257
Market cap: 70718324736 (Large Cap ($10B-$200B))
Debt to equity: 0.46064003404447645
Free cash flow (dilution adjusted): -123076285.71428572
Operating income: 467683000
Net income: 416976000
Long score: 10 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 6656.HK (quarterly, report date 2025-12-31)
Altman Z-score: 10.3555885130957 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 42.46107504772801%
Earnings yield: 1.7853601993586492%
Return on net tangible assets: 24.13573237675875%
Capitalized R&D asset: 22122010.567514677
ROCI (R&D adjusted): 32.21367009274593%
Free cash flow margin: -18.709811643774458%
Rule of 40 score: -18.709811643774458
Market cap: 70718324736 (Large Cap ($10B-$200B))
Debt to equity: 0.46064003404447645
Free cash flow (dilution adjusted): -89801857.14285713
Operating income: 181964571.42857143
Net income: 146972571.42857143
Long score: 8 | Short score: 4
Recommendation: Long
Stock screener scorecard for BALKRISIND.NS (annual, report date 2026-03-31)
Altman Z-score: 4.756887158560788 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 16.8772476769164%
Earnings yield: 0.04435545172438942%
Return on net tangible assets: -8.957002987768506%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.322484054225889%
Free cash flow margin: -7.02700284539699%
Revenue growth: -6.087973902789318%
Rule of 40 score: -13.114976748186308
Market cap: 389244157952 (Mega Cap (>= $200B))
Debt to equity: 0.3527
Free cash flow (dilution adjusted): -79903560.83086054
Operating income: 192423696.48156
Net income: 131740144.12886816
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BALKRISIND.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.062709123017171 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 4.100078729691319%
Earnings yield: 0.010775503662825104%
Return on net tangible assets: 4.551711413166093%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.479436537948813%
Revenue growth: 1.9499994827362512%
Rule of 40 score: 1.9499994827362512
Market cap: 389244157952 (Mega Cap (>= $200B))
Debt to equity: 0.3527
Operating income: 46746502.75540483
Net income: 31735905.044510387
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for BCO.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.978363273673665 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 1.2836009900420193%
Earnings yield: 0.2535408037893163%
Capitalized R&D asset: 1844890000
ROCI (R&D adjusted): 0.7001185836082648%
Rosenberg metric: 0.7614107883817427
Free cash flow margin: -7.2692082639420255%
Revenue growth: -7.228161015533656%
Rule of 40 score: -14.49736927947568
Market cap: 146466570240 (Large Cap ($10B-$200B))
Debt to equity: 8.287
Free cash flow (dilution adjusted): -1615000000
Operating income: 446000000
Net income: -4000000
Long score: 0 | Short score: 9
Recommendation: Short
Stock screener scorecard for CWAN (quarterly, report date 2026-03-31)
Altman Z-score: 4.7926636326724585 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 3.6564781485774716%
Earnings yield: 0.11115334471121555%
Capitalized R&D asset: 112427480
ROCI (R&D adjusted): 0.35447009388684847%
Rosenberg metric: -0.011822694662246312
Free cash flow margin: -7.838067514057895%
Revenue growth: 1.7341359441176878%
Rule of 40 score: -6.103931569940206
Market cap: 7330872320 (Mid Cap ($2B-$10B))
Debt to equity: 0.419
Free cash flow (dilution adjusted): -17340000
Operating income: 8990000
Net income: -2776000
Long score: 5 | Short score: 8
Recommendation: Neutral
Stock screener scorecard for 0901.HK (annual, report date 2025-12-31)
Altman Z-score: 8.49645152063085 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 20.82280577392963%
Earnings yield: 0.29256666488687705%
Return on net tangible assets: 18.962536251720838%
Capitalized R&D asset: 45090254.98773811
ROCI (R&D adjusted): 16.906047089886908%
Rosenberg metric: 1.2523883009079577
Free cash flow margin: -4.62704210847951%
Revenue growth: 38.21628104199173%
Rule of 40 score: 33.58923893351222
Market cap: 12750512128 (Large Cap ($10B-$200B))
Debt to equity: 0.18280000000000002
Free cash flow (dilution adjusted): -22260428.57142857
Operating income: 37180428.571428575
Net income: 34164714.28571428
Long score: 12 | Short score: 2
Recommendation: Long
Stock screener scorecard for ASHOKA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.0340746403033974 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 3.6679662798261554%
Earnings yield: 0.054553475547329644%
Return on net tangible assets: 3.1769042253932103%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.620542514833631%
Revenue growth: 1.7460236085284428%
Rule of 40 score: 1.7460236085284428
Market cap: 33931018240 (Large Cap ($10B-$200B))
Debt to equity: 0.2446
Operating income: 23586403.136922427
Net income: 15558202.628232302
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for ASHOKA.NS (annual, report date 2026-03-31)
Altman Z-score: 1.8396409266882392 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 28.37491881194581%
Earnings yield: 0.42201872140392604%
Return on net tangible assets: 44.49781931230066%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 20.27218230184515%
Free cash flow margin: 7.146051816039341%
Revenue growth: -32.07891259843555%
Rule of 40 score: -24.93286078239621
Market cap: 33931018240 (Large Cap ($10B-$200B))
Debt to equity: 0.2446
Free cash flow (dilution adjusted): 56949427.7236117
Operating income: 182461403.13692242
Net income: 272976038.5756677
Long score: 10 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ARFIN.NS (annual, report date 2026-03-31)
Altman Z-score: 7.05629292028601 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 21.249436936936934%
Earnings yield: 0.026036241292554677%
Return on net tangible assets: 5.136756311242712%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 21.0790543878793%
Free cash flow margin: 1.1901776042983097%
Revenue growth: -9.017697035109173%
Rule of 40 score: -7.827519430810863
Market cap: 15520780288 (Large Cap ($10B-$200B))
Debt to equity: 0.7587999999999999
Free cash flow (dilution adjusted): 779482.831708351
Operating income: 4399417.125900805
Net income: 1637484.1034336584
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for ARFIN.NS (quarterly, report date 2026-03-31)
Altman Z-score: 5.6769363663584675 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 7.670915233415234%
Earnings yield: 0.009398921982952172%
Return on net tangible assets: 4.794630718041078%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.609408187607237%
Revenue growth: -2.1915394712629555%
Rule of 40 score: -2.1915394712629555
Market cap: 15520780288 (Large Cap ($10B-$200B))
Debt to equity: 0.7587999999999999
Operating income: 1588162.356930903
Net income: 723219.5845697329
Long score: 3 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ARRD.DE (quarterly, report date 2026-03-31)
Altman Z-score: 0.9358644506738797 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 1.5143592631324914%
Earnings yield: 1.5397769692147285%
Return on net tangible assets: 0.11869794391019176%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.987411487018096%
Free cash flow margin: -8.281037717538979%
Revenue growth: 0.8727985215861824%
Rule of 40 score: -7.408239195952796
Market cap: 44458299392 (Large Cap ($10B-$200B))
Debt to equity: 0.23920000000000002
Free cash flow (dilution adjusted): -1471264367.816092
Operating income: 865517241.3793104
Net income: 667816091.954023
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for AZUL (quarterly, report date 2026-03-31)
Altman Z-score: -1.1804282929413334 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 14.102610108542764%
Earnings yield: 0.6397985997950976%
Return on net tangible assets: -125.72726248236566%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.050769922965755%
Free cash flow margin: -5.999194351394387%
Revenue growth: 2.4005123196247906%
Rule of 40 score: -3.598682031769596
Market cap: 1546100480 (Small Cap ($300M-$2B))
Debt to equity: -5.469114721366818
Free cash flow (dilution adjusted): -62402661.59695818
Operating income: 128508935.36121674
Net income: 1144561026.6159697
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for OMINFRAL.NS (annual, report date 2026-03-31)
Altman Z-score: 1.399999336065196 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 6.4068508911456865%
Earnings yield: 0.02783181214235496%
Return on net tangible assets: 4.699985984212942%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.643789951377926%
Free cash flow margin: -2.2879037547794647%
Revenue growth: -36.39130643257087%
Rule of 40 score: -38.679210187350336
Market cap: 8388061696 (Mid Cap ($2B-$10B))
Debt to equity: 0.106
Free cash flow (dilution adjusted): -1212462.9080118695
Operating income: 2480955.913522679
Net income: 2178815.175922001
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for OMINFRAL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.1474686232022515 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.933143000392999%
Earnings yield: 0.01708585059584261%
Return on net tangible assets: 1.9870425064289803%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.6230132585326913%
Revenue growth: 36.220288090699356%
Rule of 40 score: 36.220288090699356
Market cap: 8388061696 (Mid Cap ($2B-$10B))
Debt to equity: 0.106
Operating income: 1523050.0211954217
Net income: 685481.1360746078
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MAIR (quarterly, report date 2026-03-31)
Altman Z-score: 1.692925803220167 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 16.596479861785983%
Earnings yield: 0.6406318916486332%
Return on net tangible assets: -1.3779830638953041%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.026554856743536%
Free cash flow margin: 5.380534805672838%
Revenue growth: 33.79200463499421%
Rule of 40 score: 39.172539440667045
Market cap: 17410748416 (Large Cap ($10B-$200B))
Debt to equity: 5.6114
Free cash flow (dilution adjusted): 49700000
Operating income: 153700000
Net income: 43000000
Long score: 3 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for NITTAGELA.NS (quarterly, report date 2026-03-31)
Altman Z-score: 16.752198491061023 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 8.26962717243524%
Earnings yield: 0.02554987754587198%
Return on net tangible assets: 7.464118385022384%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.934735724635254%
Revenue growth: 2.773498965437711%
Rule of 40 score: 2.773498965437711
Market cap: 17332115456 (Large Cap ($10B-$200B))
Debt to equity: 0.008199999999999999
Operating income: 4396206.019499788
Net income: 3613363.7134378976
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for NITTAGELA.NS (annual, report date 2026-03-31)
Altman Z-score: 17.90505383822653 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 24.51766854190173%
Earnings yield: 0.07574989971058124%
Return on net tangible assets: 12.074364034454524%
Capitalized R&D asset: 469753.7917010371
ROCI (R&D adjusted): 23.25453516420996%
Rosenberg metric: 1.1552457310362052
Free cash flow margin: 12.36793576074474%
Revenue growth: -0.3750891505189587%
Rule of 40 score: 11.992846610225781
Market cap: 17332115456 (Large Cap ($10B-$200B))
Debt to equity: 0.008199999999999999
Free cash flow (dilution adjusted): 7449470.114455278
Operating income: 13033806.697753286
Net income: 10305701.568461213
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CHI.AX (annual, report date 2025-12-31)
Altman Z-score: 1.0224908446371455 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.4227399008657886%
Earnings yield: 1.8147743501036133%
Return on net tangible assets: 0.8795627480533842%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.3612257440727054%
Free cash flow margin: 17.77332863973716%
Revenue growth: -0.224042078933879%
Rule of 40 score: 17.549286560803278
Market cap: 1089843456 (Small Cap ($300M-$2B))
Debt to equity: 0.4304
Free cash flow (dilution adjusted): 14008670.520231213
Operating income: 25701156.06936416
Net income: 6816763.005780347
Long score: 4 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for AKUMS.NS (annual, report date 2026-03-31)
Altman Z-score: 5.070145646816979 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 9.088823404319955%
Earnings yield: 0.043784842409559425%
Return on net tangible assets: 5.693273013994232%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.592672960483506%
Free cash flow margin: 22.361894268775632%
Revenue growth: -5.3342543146504955%
Rule of 40 score: 17.027639954125135
Market cap: 105227042816 (Large Cap ($10B-$200B))
Debt to equity: 0.0576
Free cash flow (dilution adjusted): 100749576.09156422
Operating income: 39632365.40907164
Net income: 27172212.80203476
Long score: 7 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for AKUMS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 4.343272167732755 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.7123492420329915%
Earnings yield: 0.013066574059042175%
Return on net tangible assets: 3.773922294071301%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.564284611397249%
Revenue growth: -5.005380705311871%
Rule of 40 score: -5.005380705311871
Market cap: 105227042816 (Large Cap ($10B-$200B))
Debt to equity: 0.0576
Operating income: 11827363.289529461
Net income: 8967041.119118271
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for HINDWAREAP.NS (annual, report date 2026-03-31)
Altman Z-score: 1.7549527690635724 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 8.93931448729561%
Earnings yield: 0.038165119815061085%
Return on net tangible assets: -6.417616665299762%
Capitalized R&D asset: 184982.3250654834
ROCI (R&D adjusted): 7.736505874548569%
Rosenberg metric: -49.21552369826182
Free cash flow margin: 5.195834727600109%
Revenue growth: -9.803860317728843%
Rule of 40 score: -4.608025590128734
Market cap: 17724663808 (Large Cap ($10B-$200B))
Debt to equity: 1.1473
Free cash flow (dilution adjusted): 13822594.31962696
Operating income: 9936413.73463332
Net income: -4159601.526070369
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for HINDWAREAP.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.9135742603882426 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 2.718215188063117%
Earnings yield: 0.011605029500078834%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.3848759881216277%
Revenue growth: -1.4978599736817695%
Rule of 40 score: -1.4978599736817695
Market cap: 17724663808 (Large Cap ($10B-$200B))
Debt to equity: 1.1473
Operating income: 3021407.3760067825
Net income: -1994489.1903348877
Long score: 0 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for BAJAJELEC.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.3222433769274728 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 1.4830525121253921%
Earnings yield: 0.0021667264875877192%
Return on net tangible assets: -2.762332005901303%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.5839805462102093%
Revenue growth: 12.355902268866467%
Rule of 40 score: 12.355902268866467
Market cap: 37952679936 (Large Cap ($10B-$200B))
Debt to equity: 0.8478
Operating income: 1120178.0415430267
Net income: -7156634.167019924
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for BAJAJELEC.NS (annual, report date 2026-03-31)
Altman Z-score: 2.093278094015697 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 4.649783533262468%
Earnings yield: 0.006793292254116202%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.830941996532802%
Free cash flow margin: 11.742884898678966%
Revenue growth: -16.26733069062655%
Rule of 40 score: -4.524445791947585
Market cap: 37952679936 (Large Cap ($10B-$200B))
Debt to equity: 0.8478
Free cash flow (dilution adjusted): 55357842.30606189
Operating income: 3512070.792708775
Net income: -9628645.61254769
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for AWL.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.45228958653503 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.773072358920835%
Earnings yield: 0.018149001646606176%
Return on net tangible assets: 4.3178743277522535%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.2103789682668413%
Revenue growth: 9.77272684085227%
Rule of 40 score: 9.77272684085227
Market cap: 243356221440 (Mega Cap (>= $200B))
Debt to equity: 0.10619999999999999
Operating income: 41951038.57566766
Net income: 31057651.54726579
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for AWL.NS (annual, report date 2026-03-31)
Altman Z-score: 4.795605247908725 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 17.81917656758598%
Earnings yield: 0.08571271210891443%
Return on net tangible assets: 6.872184970576499%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 15.161731406808581%
Free cash flow margin: 4.112650620089808%
Revenue growth: 6.413686605623275%
Rule of 40 score: 10.526337225713084
Market cap: 243356221440 (Mega Cap (>= $200B))
Debt to equity: 0.10619999999999999
Free cash flow (dilution adjusted): 325224671.4709623
Operating income: 198123145.40059346
Net income: 110734421.36498517
Long score: 9 | Short score: 0
Recommendation: Long
Stock screener scorecard for CSNA3.SA (quarterly, report date 2026-03-31)
Altman Z-score: 0.18428523956798415 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0.7304147625919184%
Earnings yield: 0.10833843640679136%
Return on net tangible assets: -27.74013408136212%
Capitalized R&D asset: 4823078.082981176
ROCI (R&D adjusted): 0.3505011754763973%
Rosenberg metric: -35.073074718355464
Free cash flow margin: -17.937899834134495%
Revenue growth: -14.349143223132405%
Rule of 40 score: -32.2870430572669
Market cap: 6192858624 (Mid Cap ($2B-$10B))
Debt to equity: 3.2393
Free cash flow (dilution adjusted): -361614828.8973384
Operating income: 51438593.15589354
Net income: -105517680.60836503
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for BAJAJCON.NS (annual, report date 2026-03-31)
Altman Z-score: 26.52809430856027 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 33.56904511557725%
Earnings yield: 0.03217894401267885%
Return on net tangible assets: 28.36593884253591%
Capitalized R&D asset: 82275.81961419401
ROCI (R&D adjusted): 26.70399834968994%
Rosenberg metric: 278.39737493866676
Free cash flow margin: 14.06091789964741%
Revenue growth: 10.09436380050619%
Rule of 40 score: 24.1552817001536
Market cap: 73022169088 (Large Cap ($10B-$200B))
Debt to equity: 0.0209
Free cash flow (dilution adjusted): 17187685.459940653
Operating income: 21836763.459092837
Net income: 20154832.556167867
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BBTC.NS (annual, report date 2026-03-31)
Altman Z-score: 3.7581385247112724 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 85.90861489581026%
Earnings yield: 0.28020490685038607%
Return on net tangible assets: 45.23682013378616%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 31.30917349187004%
Free cash flow margin: 11.360242814191533%
Revenue growth: -2.4830517637044767%
Rule of 40 score: 8.877191050487056
Market cap: 101741387776 (Large Cap ($10B-$200B))
Debt to equity: 0.16570000000000001
Free cash flow (dilution adjusted): 231647944.0440865
Operating income: 332970538.36371344
Net income: 264863289.52946165
Long score: 11 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for BBTC.NS (quarterly, report date 2026-03-31)
Altman Z-score: 2.219457090083095 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 20.329918217686963%
Earnings yield: 0.06630933169358735%
Return on net tangible assets: 14.467499808734352%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.4091863467366075%
Revenue growth: -8.566337479720008%
Rule of 40 score: -8.566337479720008
Market cap: 101741387776 (Large Cap ($10B-$200B))
Debt to equity: 0.16570000000000001
Operating income: 78796100.04239084
Net income: 82746926.6638406
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for EFX.TO (quarterly, report date 2026-03-31)
Altman Z-score: 1.9604662563354274 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 6.554121151936444%
Earnings yield: 1.0549463638896217%
Return on net tangible assets: 9.857142857142858%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.5908596300326447%
Free cash flow margin: -1.027397260273973%
Revenue growth: -8.198226108108704%
Rule of 40 score: -9.225623368382678
Market cap: 3926893568 (Mid Cap ($2B-$10B))
Debt to equity: 0.5447
Free cash flow (dilution adjusted): -4316546.76258993
Operating income: 47482014.38848921
Net income: 30935251.798561152
Long score: 4 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for MLHBP.PA (annual, report date 2021-12-31)
Altman Z-score: 10.171851598967134 (Safe Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 19.491091242433058%
Earnings yield: 1.1092214977927566%
Return on net tangible assets: 64.5448164710501%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.355965639164907%
Rule of 40 score: 0
Market cap: 79825592 (Micro Cap ($50M-$300M))
Debt to equity: 10.036383361733707
Operating income: 1044628.8181818181
Net income: 254571.51136363635
Long score: 5 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ANTELOPUS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 11.680004593476287 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 6.947302686668842%
Earnings yield: 0.01684394806228542%
Return on net tangible assets: 6.2591429839412225%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.462643412592582%
Revenue growth: 36.475709855868146%
Rule of 40 score: 36.475709855868146
Market cap: 31450974208 (Large Cap ($10B-$200B))
Debt to equity: 0.0054
Operating income: 5187579.482831708
Net income: 4035608.3086053412
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ANTELOPUS.NS (annual, report date 2026-03-31)
Altman Z-score: 12.144224520911397 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 15.793582083197322%
Earnings yield: 0.038292023296652135%
Return on net tangible assets: -13.461759726491229%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.691786699761034%
Free cash flow margin: -36.09796328169822%
Revenue growth: -2.04100216894998%
Rule of 40 score: -38.1389654506482
Market cap: 31450974208 (Large Cap ($10B-$200B))
Debt to equity: 0.0054
Free cash flow (dilution adjusted): -10668715.557439592
Operating income: 11793132.683340399
Net income: 9496608.732513778
Long score: 6 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for AOF.DE (annual, report date 2025-12-31)
Altman Z-score: 15.43970911271256 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 71.13848570144566%
Earnings yield: 8.20883417635881%
Return on net tangible assets: 53.7130590319393%
Capitalized R&D asset: 60154265.5680147
ROCI (R&D adjusted): 45.08339169602865%
Rosenberg metric: 1.399702227267833
Free cash flow margin: 24.42785084554357%
Revenue growth: 25.274688588828848%
Rule of 40 score: 49.70253943437242
Market cap: 1210467328 (Small Cap ($300M-$2B))
Debt to equity: 0.0704
Free cash flow (dilution adjusted): 54390263.52941176
Operating income: 81062408.23529412
Net income: 56902903.52941176
Long score: 18 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ASTERDM.NS (quarterly, report date 2026-03-31)
Altman Z-score: 12.873334772207174 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.096544620282798%
Earnings yield: 0.004208266709847042%
Return on net tangible assets: 5.152760374007984%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 2.31802377747869%
Revenue growth: -5.135532760411552%
Rule of 40 score: -5.135532760411552
Market cap: 683901124608 (Mega Cap (>= $200B))
Debt to equity: 0.4592
Operating income: 17522255.19287834
Net income: 16275964.391691394
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ASTERDM.NS (annual, report date 2026-03-31)
Altman Z-score: 13.491753995181645 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 11.925835752411276%
Earnings yield: 0.016207451769060115%
Return on net tangible assets: 5.202929900337654%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 8.927489905787349%
Free cash flow margin: 3.663190630639944%
Revenue growth: 1.7095688241147027%
Rule of 40 score: 5.372759454754647
Market cap: 683901124608 (Mega Cap (>= $200B))
Debt to equity: 0.4592
Free cash flow (dilution adjusted): 18025646.46036456
Operating income: 67484103.43365833
Net income: 45262823.23018228
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for BCLIND.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.6149477652194466 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 3.5497035857830905%
Earnings yield: 0.03009592220713361%
Return on net tangible assets: 4.309524339454622%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 3.252824693247475%
Revenue growth: -23.726793644077706%
Rule of 40 score: -23.726793644077706
Market cap: 10549137408 (Large Cap ($10B-$200B))
Debt to equity: 0.5985
Operating income: 4415674.014412886
Net income: 2760057.22763883
Long score: 1 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for BCLIND.NS (annual, report date 2026-03-31)
Altman Z-score: 3.2553348627532217 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 16.289483203478355%
Earnings yield: 0.1381092836173086%
Return on net tangible assets: 5.033485908284463%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.927114877065176%
Free cash flow margin: 6.9184253981927375%
Revenue growth: -10.103384325011195%
Rule of 40 score: -3.1849589268184575
Market cap: 10549137408 (Large Cap ($10B-$200B))
Debt to equity: 0.5985
Free cash flow (dilution adjusted): 20468281.051292922
Operating income: 20263395.50657058
Net income: 13399544.298431538
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for MAFATIND.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.4774500730801055 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 2.8540031397174257%
Earnings yield: 1.019575047688475%
Return on net tangible assets: 2.9271159874608155%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.1067280298049529%
Revenue growth: 17.18898037789659%
Rule of 40 score: 17.18898037789659
Market cap: 9592579072 (Mid Cap ($2B-$10B))
Debt to equity: 0.08240219842895288
Operating income: 963331.9203052141
Net income: 1903348.876642645
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for MAFATIND.NS (annual, report date 2026-03-31)
Altman Z-score: 3.339111073565778 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 31.18053375196232%
Earnings yield: 11.13905368382205%
Return on net tangible assets: 10.748432601880879%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.09121679207149%
Free cash flow margin: 2.9749021892949306%
Revenue growth: 24.43366350044957%
Rule of 40 score: 27.4085656897445
Market cap: 9592579072 (Mid Cap ($2B-$10B))
Debt to equity: 0.08240219842895288
Free cash flow (dilution adjusted): 12119542.17888936
Operating income: 10524586.689275116
Net income: 9535820.26282323
Long score: 12 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ANUP.NS (quarterly, report date 2026-03-31)
Altman Z-score: 9.843843672841025 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 4.2829179751697675%
Earnings yield: 0.00748883467229837%
Return on net tangible assets: 5.078765984677589%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.1339287373765545%
Revenue growth: -4.4303633956795965%
Rule of 40 score: -4.4303633956795965
Market cap: 42458697728 (Large Cap ($10B-$200B))
Debt to equity: 0.159
Operating income: 3252850.784230606
Net income: 2813109.3683764306
Long score: 4 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ANUP.NS (annual, report date 2026-03-31)
Altman Z-score: 10.869948499334196 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 20.417141439452482%
Earnings yield: 0.035700099233147445%
Return on net tangible assets: 12.814971584781507%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 19.706893342567163%
Free cash flow margin: -6.614375965978818%
Revenue growth: 1.7250575566485107%
Rule of 40 score: -4.889318409330307
Market cap: 42458697728 (Large Cap ($10B-$200B))
Debt to equity: 0.159
Free cash flow (dilution adjusted): -5764010.173802459
Operating income: 15506697.75328529
Net income: 11699067.40144129
Long score: 8 | Short score: 2
Recommendation: Long
Stock screener scorecard for TRANSPEK.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.8911579857130694 (Grey Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 1.1029176436540982%
Earnings yield: 1.2000073910227682%
Return on net tangible assets: 2.3744349119855017%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.6946190775398351%
Revenue growth: -11.025016594243743%
Rule of 40 score: -11.025016594243743
Market cap: 5948072448 (Mid Cap ($2B-$10B))
Debt to equity: 0.03812473002828228
Operating income: 644595.1674438321
Net income: 697361.1699872827
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for TRANSPEK.NS (annual, report date 2026-03-31)
Altman Z-score: 2.486784555103131 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 8.114035127484504%
Earnings yield: 8.828312957022115%
Return on net tangible assets: 7.462152312793685%
Capitalized R&D asset: 162048.4527336936
ROCI (R&D adjusted): 4.983344496164772%
Rosenberg metric: -13.161714120222022
Free cash flow margin: 6.47550945832173%
Revenue growth: -13.344353509353047%
Rule of 40 score: -6.868844051031317
Market cap: 5948072448 (Mid Cap ($2B-$10B))
Debt to equity: 0.03812473002828228
Free cash flow (dilution adjusted): 4263013.98897838
Operating income: 4742210.682492581
Net income: 4837367.52861382
Long score: 9 | Short score: 1
Recommendation: Long
Stock screener scorecard for GOAI (annual, report date 2025-12-31)
Piotroski F-score: 6 (Neutral)
Return on capital: 84.79560256739028%
Earnings yield: 12.620657079033796%
Return on net tangible assets: 84.74659389189539%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 84.79560256739028%
Free cash flow margin: -2.695035277832299%
Revenue growth: 82.5890145837984%
Rule of 40 score: 79.8939793059661
Market cap:  (Unknown)
Debt to equity: 0.10164116654470373
Free cash flow (dilution adjusted): -459162
Operating income: 8220257
Net income: 8127313
Long score: 13 | Short score: 2
Recommendation: Long